Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Haddad

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
The Laryngoscope|October 29, 2004
Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancerChristopher A Sullivan, Michael T Jaklitsch, Robert Haddad, et al.
Cancer|January 9, 2003
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experienceRobert Haddad, A Dimitrios Colevas, Roy Tishler, et al.
Psychotherapy and Psychosomatics|December 11, 2003
A method for rating charts to identify and classify patients with medically unexplained symptomsRobert C Smith, Elie Korban, Mohammed Kanj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
HER2 expression in salivary gland carcinomas: dependence on histological subtypeBonnie Glisson, A Dimitrios Colevas, Robert Haddad, et al.
The Lancet. Oncology|February 19, 2013
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trialRobert Haddad, Anne O'Neill, Guilherme Rabinowits, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 23, 2023
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancerEric R Reed, Stacy A Jankowski, Anthony J Spinella, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neckEthan J Harris, Julian Huang, Erin Carroll, et al.
The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.
JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Laryngoscope|October 29, 2004
Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancerChristopher A Sullivan, Michael T Jaklitsch, Robert Haddad, et al.
Cancer|January 9, 2003
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experienceRobert Haddad, A Dimitrios Colevas, Roy Tishler, et al.
Psychotherapy and Psychosomatics|December 11, 2003
A method for rating charts to identify and classify patients with medically unexplained symptomsRobert C Smith, Elie Korban, Mohammed Kanj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
HER2 expression in salivary gland carcinomas: dependence on histological subtypeBonnie Glisson, A Dimitrios Colevas, Robert Haddad, et al.
The Lancet. Oncology|February 19, 2013
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trialRobert Haddad, Anne O'Neill, Guilherme Rabinowits, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 23, 2023
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancerEric R Reed, Stacy A Jankowski, Anthony J Spinella, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neckEthan J Harris, Julian Huang, Erin Carroll, et al.
The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.
JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
Pageof 8